Big-money moves in the US on 23/01/17 (Tue)

Insider buys: 96 trades
Insider sales: 201 trades
Congress trades: 3 trades

Notable trades of the day

No trade stood out on this day.

Trades disclosed this day

Adam D. GoldsteinCEO
BuyArcher Aviation
Buy
Archer Aviation
ACHR
$100.4K
39,526 sh
$100.4K
Filed 23/01/17
Traded 23/01/12
Mark MeslerCFO
BuyArcher Aviation
Buy
Archer Aviation
ACHR
$52.6K
20,000 sh
$52.6K
Filed 23/01/17
Traded 23/01/13
Ares Voting10% Owner
BuyClear Channel Outdoor Holdings
Buy
Clear Channel Outdoor Holdings
CCO
$458.7K
330,000 sh
$458.7K
Filed 23/01/17
Traded 23/01/13
Ares Partners Holdco10% Owner
BuyClear Channel Outdoor Holdings
Buy
Clear Channel Outdoor Holdings
CCO
$458.7K
330,000 sh
$458.7K
Filed 23/01/17
Traded 23/01/13
Ares Holdco10% Owner
BuyClear Channel Outdoor Holdings
Buy
Clear Channel Outdoor Holdings
CCO
$458.7K
330,000 sh
$458.7K
Filed 23/01/17
Traded 23/01/13
Ares Management Holdings10% Owner
BuyClear Channel Outdoor Holdings
Buy
Clear Channel Outdoor Holdings
CCO
$458.7K
330,000 sh
$458.7K
Filed 23/01/17
Traded 23/01/13
Ares Management GP10% Owner
BuyClear Channel Outdoor Holdings
Buy
Clear Channel Outdoor Holdings
CCO
$458.7K
330,000 sh
$458.7K
Filed 23/01/17
Traded 23/01/13
Ares Management10% Owner
BuyClear Channel Outdoor Holdings
Buy
Clear Channel Outdoor Holdings
CCO
$458.7K
330,000 sh
$458.7K
Filed 23/01/17
Traded 23/01/13
Ares Management10% Owner
BuyClear Channel Outdoor Holdings
Buy
Clear Channel Outdoor Holdings
CCO
$458.7K
330,000 sh
$458.7K
Filed 23/01/17
Traded 23/01/13
Assf IV Aiv B10% Owner
BuyClear Channel Outdoor Holdings
Buy
Clear Channel Outdoor Holdings
CCO
$458.7K
330,000 sh
$458.7K
Filed 23/01/17
Traded 23/01/13
Assf Operating Manager IV10% Owner
BuyClear Channel Outdoor Holdings
Buy
Clear Channel Outdoor Holdings
CCO
$458.7K
330,000 sh
$458.7K
Filed 23/01/17
Traded 23/01/13
Asof Investment Management10% Owner
BuyClear Channel Outdoor Holdings
Buy
Clear Channel Outdoor Holdings
CCO
$458.7K
330,000 sh
$458.7K
Filed 23/01/17
Traded 23/01/13
Assf IV AIV B Holdings III10% Owner
BuyClear Channel Outdoor Holdings
Buy
Clear Channel Outdoor Holdings
CCO
$458.7K
330,000 sh
$458.7K
Filed 23/01/17
Traded 23/01/13
Asof Holdings I10% Owner
BuyClear Channel Outdoor Holdings
Buy
Clear Channel Outdoor Holdings
CCO
$458.7K
330,000 sh
$458.7K
Filed 23/01/17
Traded 23/01/13
Acof VI Holdings10% Owner
BuyClear Channel Outdoor Holdings
Buy
Clear Channel Outdoor Holdings
CCO
$458.7K
330,000 sh
$458.7K
Filed 23/01/17
Traded 23/01/13
Acof Investment Management10% Owner
BuyClear Channel Outdoor Holdings
Buy
Clear Channel Outdoor Holdings
CCO
$458.7K
330,000 sh
$458.7K
Filed 23/01/17
Traded 23/01/13
Ares Management10% Owner
BuyClear Channel Outdoor Holdings
Buy
Clear Channel Outdoor Holdings
CCO
$458.7K
330,000 sh
$458.7K
Filed 23/01/17
Traded 23/01/13
Ledo CapitalOther
BuyMerrimack Pharmaceuticals
Buy
Merrimack Pharmaceuticals
MACK
$1.2M
100,000 sh
$1.2M
Filed 23/01/17
Traded 23/01/12
Noah G. LevyDirector
BuyMerrimack Pharmaceuticals
Buy
Merrimack Pharmaceuticals
MACK
$1.2M
100,000 sh
$1.2M
Filed 23/01/17
Traded 23/01/12
Newtyn Capital PartnersOther
BuyMerrimack Pharmaceuticals
Buy
Merrimack Pharmaceuticals
MACK
$1.2M
100,000 sh
$1.2M
Filed 23/01/17
Traded 23/01/12
Newtyn ManagementOther
BuyMerrimack Pharmaceuticals
Buy
Merrimack Pharmaceuticals
MACK
$1.2M
100,000 sh
$1.2M
Filed 23/01/17
Traded 23/01/12
Newtyn Te PartnersOther
BuyMerrimack Pharmaceuticals
Buy
Merrimack Pharmaceuticals
MACK
$1.2M
100,000 sh
$1.2M
Filed 23/01/17
Traded 23/01/12
Newtyn PartnersOther
BuyMerrimack Pharmaceuticals
Buy
Merrimack Pharmaceuticals
MACK
$1.2M
100,000 sh
$1.2M
Filed 23/01/17
Traded 23/01/12
Michael SpellacyDirector
BuyArcher Aviation
Buy
Archer Aviation
ACHR
$60.1K
23,116 sh
$60.1K
Filed 23/01/17
Traded 23/01/13
Fred M. DiazDirector
BuyArcher Aviation
Buy
Archer Aviation
ACHR
$50K
19,322 sh
$50K
Filed 23/01/17
Traded 23/01/12
TCG Opportunity III GP10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$26.6K
5,378 sh
$26.6K
Filed 23/01/17
Traded 23/01/12
Column Group GP10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$26.6K
5,378 sh
$26.6K
Filed 23/01/17
Traded 23/01/12
Column Group IV-A10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$26.6K
5,378 sh
$26.6K
Filed 23/01/17
Traded 23/01/12
Column Group Opportunity III10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$26.6K
5,378 sh
$26.6K
Filed 23/01/17
Traded 23/01/12
Column Group Iii-A10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$26.6K
5,378 sh
$26.6K
Filed 23/01/17
Traded 23/01/12
Column Group Opportunity III GP10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$26.6K
5,378 sh
$26.6K
Filed 23/01/17
Traded 23/01/12
Column Group III10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$26.6K
5,378 sh
$26.6K
Filed 23/01/17
Traded 23/01/12
TCG IV GP10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$26.6K
5,378 sh
$26.6K
Filed 23/01/17
Traded 23/01/12
Column Group IV10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$26.6K
5,378 sh
$26.6K
Filed 23/01/17
Traded 23/01/12
Column Group IV GP10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$26.6K
5,378 sh
$26.6K
Filed 23/01/17
Traded 23/01/12
Ponoi Capital10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$26.6K
5,378 sh
$26.6K
Filed 23/01/17
Traded 23/01/12
Ponoi Capital II10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$26.6K
5,378 sh
$26.6K
Filed 23/01/17
Traded 23/01/12
Column Group II GP10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$26.6K
5,378 sh
$26.6K
Filed 23/01/17
Traded 23/01/12
Tim Kutzkey10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$26.6K
5,378 sh
$26.6K
Filed 23/01/17
Traded 23/01/12
Peter Svennilson10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$26.6K
5,378 sh
$26.6K
Filed 23/01/17
Traded 23/01/12
Ponoi Management10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$26.6K
5,378 sh
$26.6K
Filed 23/01/17
Traded 23/01/12
Column Group Management10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$26.6K
5,378 sh
$26.6K
Filed 23/01/17
Traded 23/01/12
Column Group II10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$26.6K
5,378 sh
$26.6K
Filed 23/01/17
Traded 23/01/12
Ponoi II Management10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$26.6K
5,378 sh
$26.6K
Filed 23/01/17
Traded 23/01/12
Saba Capital Management10% Owner
BuyClearBridge Energy Midstream Opportunity Fund
Buy
ClearBridge Energy Midstream Opportunity Fund
EMO
$307.8K
10,630 sh
$307.8K
Filed 23/01/17
Traded 23/01/10
Boaz Weinstein10% Owner
BuyClearBridge Energy Midstream Opportunity Fund
Buy
ClearBridge Energy Midstream Opportunity Fund
EMO
$307.8K
10,630 sh
$307.8K
Filed 23/01/17
Traded 23/01/10
Michael T. KerrDirector
BuyEog Resources
Buy
Eog Resources
EOG
$2.6M
20,000 sh
$2.6M
Filed 23/01/17
Traded 23/01/12
Mark A. StevensDirector
SellNvidia
Sell
Nvidia
NVDA
$7.4M
45,000 sh
$7.4M
Filed 23/01/17
Traded 23/01/12
Wes CumminsCEO; Chairman
BuyApplied Digital
Buy
Applied Digital
APLD
$162.8K
75,000 sh
$162.8K
Filed 23/01/17
Traded 23/01/13
Mark A. StevensDirector
SellNvidia
Sell
Nvidia
NVDA
$3.3M
20,000 sh
$3.3M
Filed 23/01/17
Traded 23/01/13